Early Conversion of Intensive Insulin Therapy to IDegLira Demonstrates Higher Efficacy and Safety in Reducing Fasting Blood Glucose and HbA1c in T2DM Patients. | Diabetes Metab Syndr Obes;17: 3217-3226, 2024. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Early Conversion of Intensive Insulin Therapy to IDegLira Demonstrates Higher Efficacy and Safety in Reducing Fasting Blood Glucose and HbA1c in T2DM Patients.

Guo, Caiyun; Lu, Yang.

Affiliation

Guo C; Department of Endocrinology, YuYao People's Hospital, Ningbo, Zhejiang Province, People's Republic of China.
Lu Y; Department of Endocrinology, YuYao People's Hospital, Ningbo, Zhejiang Province, People's Republic of China.

Diabetes Metab Syndr Obes ; 17: 3217-3226, 2024.

Article in En | MEDLINE | ID: mdl-39224113

Key words

IDegLira; T2DM; early conversion; insulin intensive therapy; safety

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Diabetes Metab Syndr Obes Year: 2024 Document type: Article Country of publication: Nueva Zelanda

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Diabetes Metab Syndr Obes Year: 2024 Document type: Article Country of publication: Nueva Zelanda